WallStreetZenWallStreetZen

NASDAQ: CTSO
Cytosorbents Corp Stock Ownership - Who owns Cytosorbents?

Insider buying vs selling

Have Cytosorbents Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vincent CapponiPresident COO2023-12-1318,797$1.33
$25.00kBuy
Phillip P. ChanChief Executive Officer2023-12-1375,188$1.33
$100.00kBuy
Kathleen P. BlochChief Financial Officer2023-12-1337,594$1.33
$50.00kBuy
Michael G. BatorDirector2023-12-1337,594$1.33
$50.00kBuy
Alan D. SobelDirector2023-12-1322,557$1.33
$30.00kBuy
Jiny KimDirector2023-12-137,519$1.33
$10.00kBuy
Edward Raymond JonesDirector2023-12-137,519$1.33
$10.00kBuy
Efthymios DeliargyrisChief Medical Officer2023-12-1322,557$1.33
$30.00kBuy
Michael G. BatorDirector2023-08-071,000$3.15
$3.15kBuy
Michael G. BatorDirector2023-08-071,000$3.20
$3.20kBuy

1 of 2

CTSO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTSO insiders and whales buy or sell their stock.

CTSO Shareholders

What type of owners hold Cytosorbents Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David Lamadrid14.44%7,837,500$7.29MInsider
Guillermina Vega Montiel9.20%4,993,984$4.64MInsider
Margie Chassman8.83%4,795,000$4.46MInsider
Granahan Investment Management LLC6.66%3,618,143$3.36MInstitution
Skylands Capital LLC5.99%3,254,213$3.03MInstitution
Avenir Corp5.62%3,051,402$2.84MInstitution
Robert Shipley5.48%2,972,819$2.76MInsider
Njtc Investment Fund LP4.71%2,554,999$2.38MInsider
Vanguard Group Inc3.59%1,949,551$1.81MInstitution
Neuberger Berman Group LLC3.32%1,801,799$1.68MInstitution

1 of 3

CTSO vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTSO33.04%49.73%Net Buying
PXDT0.39%0.00%
RBOT36.96%45.09%Net BuyingNet Selling
IRIX14.51%85.49%Net Buying
ICCM0.62%0.00%

Cytosorbents Stock Ownership FAQ

Who owns Cytosorbents?

Cytosorbents (NASDAQ: CTSO) is owned by 33.04% institutional shareholders, 49.73% Cytosorbents insiders, and 17.22% retail investors. David Lamadrid is the largest individual Cytosorbents shareholder, owning 7.84M shares representing 14.44% of the company. David Lamadrid's Cytosorbents shares are currently valued at $7.45M.

If you're new to stock investing, here's how to buy Cytosorbents stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.